Lacosamide

Links shared publicly online about this topic

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS

news-medical.net — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 5:41 am By:

NewsMedical News-Medical.Net Health News

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS: A recent multi-center study has confi... http://bit.ly/9sdJGi

2 years ago...

ingentaconnect Carbamazepine/lacosamide interaction: Epileptic negative myoclonu...

ingentaconnect.com — “ingentaconnect Carbamazepine/lacosamide interaction: Epileptic negative myoclonu...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on May 19, 2011 at 9:21 am By:

Epilepsy_Wisdom Epilepsy OW OW Health

Carbamazepine/lacosamide interaction: Epileptic negative myoclonus: case report: (Source: Reactions) http://bit.ly/imyEcq

1 year ago...

Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures

medicalnewstoday.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 4:07 pm By:

mnt_epilepsy MNT Epilepsy News Health News

Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures http://mnt.to/3ybp #epilepsy

2 years ago...

Internal Med Medical News about Diabetic Neuropathies Pain Lacosamide

mdlinx.com — “Efficacy and Safety of Lacosamide in Painful Diabetic NeuropathyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 19, 2010 at 10:17 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Int Med: Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy: Diabetes Care http://url4.eu/1ABhm

2 years ago...

Neurology Medical News about Anticonvulsants Vigabatrin Lacosamide Rufinamide

mdlinx.com — “New Antiepileptic Drugs: Lacosamide, Rufinamide, and VigabatrinView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 2, 2010 at 11:07 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

New Antiepileptic Drugs: Lacosamide, Rufinamide, and Vigabatrin: Current Treatment Options in Ne... http://bit.ly/an0oPO #neurology #mdlinx

2 years ago...

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures

physorg.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from the ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on February 25, 2010 at 7:11 pm By:

physorg_health PhysOrg Health News Health News

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures http://tw.physorg.com/186329360

2 years ago...

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures

sciencedaily.com — “A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures, and doses of 600mg/day may provide additional benefit for some patients.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on March 9, 2010 at 9:07 pm By:

medical_tweets medical_tweets Health News

Lacosamide validated as promising therapy for uncontrolled partial-onset seizures A recent multi-center study has con.. http://bit.ly/8X1cZx

2 years ago...

Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS

medicalnewstoday.com — “UCB has announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, accordingView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 12, 2010 at 4:11 pm By:

mnt_epilepsy MNT Epilepsy News Health News

Study Reinforces Role Of AED Vimpat (Lacosamide) (C-V) As Add-On Treatment For POS http://mnt.to/3yQt #epilepsy

2 years ago...

Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years

medicalnewstoday.com — “The 29th International Epilepsy Congress in Rome, Italy (28th August-1st September) 1-4 presented consistent evidence this week, that a combined treatment with Vimpat® (lacosamide) has generalView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 2, 2011 at 7:04 am By:

Epilepsy_Wisdom Epilepsy OW OW Health

Sustained Efficacy Of Vimpat (Lacosamide) In Reducing Partial Onset Of Seizures For Up To Eight Years: The 29th ... http://t.co/Mec2KWC

9 months ago...

ScienceDirect - Epilepsy & Behavior : Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine

sciencedirect.com — “ScienceDirect - Epilepsy & Behavior : Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepineView full resource at sciencedirect.com

  • View Related
  • Share

Most Recently Shared on May 22, 2011 at 3:53 am By:

virtualneuronet Edgar Avalos, MD Neurology and Health Group

Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine http://dx.doi.org/10.1016/j.yebeh.2011.01.022

1 year ago...

Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs

medicalnewstoday.com — “Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patientsView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 13, 2011 at 3:05 pm By:

mnt_pharma MNT Pharma News Health News and Pharma

Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomi... http://mnt.to/3PXs

1 year ago...

New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years

medicalnewstoday.com — “New long term data showed that Vimpat® (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset sView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 30, 2010 at 5:08 pm By:

mnt_epilepsy MNT Epilepsy News Health News

New Data For Vimpat (Lacosamide) C-V Showed Sustained Efficacy For Up To 5 Years http://mnt.to/3Fzh #epilepsy

2 years ago...

Research Supporting The Role Of Antiepileptic Drug Vimpat® (Lacosamide) (C-V) To Be Highlighted At Upcoming AAN Meeting

medicalnewstoday.com — “The antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) will be the subject of numerous studies and analyses at the 62nd annual American Academy of Neurology (AAN) meeting, taking place at theView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 10, 2010 at 11:37 am By:

medical_tweets medical_tweets Health News

Research Supporting The Role Of Antiepileptic Drug Vimpat® (Lacosamide) (C-V) To Be Highlighted At Upcoming AAN Meeting .. http://dld.bz/P5D

2 years ago...

New Oral Solution Formulation Of Antiepileptic Drug Vimpat (Lacosamide) (C-V)

medicalnewstoday.com — “UCB has announced the availability of an oral solution formulation of Vimpat® (lacosamide) C-V, an antiepileptic drug (AED) for add-on treatment of partial-onset seizures in people with epilepView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 16, 2010 at 12:14 pm By:

mnt_caregivers MNT Caregivers News Health News

New Oral Solution Formulation Of Antiepileptic Drug Vimpat (Lacosamide) (C-V) http://mnt.to/3DVb #caregivers

2 years ago...

Research Supporting Role Of AED Vimpat (Lacosamide)(C-V) Highlighted At AAN Meeting

medicalnewstoday.com — “The antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) will be the subject of numerous studies and analyses - both UCB-sponsored and independent - at the 62nd annual American Academy of NeuroView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 12, 2010 at 2:07 pm By:

mnt_neurology MNT Neurology News Neurology and Health News

Research Supporting Role Of AED Vimpat (Lacosamide)(C-V) Highlighted At AAN Meeting http://mnt.to/3B6m #neurology

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390